Entrega Bio
Boston
About Entrega Bio
Entrega Bio offers a proprietary technology that makes injectable substances available orally. Its technology has the potential to deliver a wide variety of biological molecules, drug substances, and nanoparticles. Entrega Bio collaborates with pharma and non-pharma industry partners to develop the platform for innovative therapeutic and diagnostic modalities. This platform enables novel applications in a variety of fields such as disease management and tracking in the burgeoning mobile health arena. Entrega Bio is based in Boston, Massachusetts, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $5.0M
- Last round: Series Unknown (Dec 2017)
- Website: entregabio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/entrega-bio-27359 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.